Eledon Pharmaceuticals Inc ELDN Balance Sheet

Income Statement

Quarter End	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	149.59M	92.79M	82.31M	106.79M	96.07M	89.07M	80.82M	120.48M
Total Current Assets	67.57M	59.52M	48.9M	73.62M	62.99M	56.13M	47.98M	87.22M
Cash and Equivalents	65.89M	56.41M	46.49M	40.95M	3.67M	4.61M	5.66M	26.04M
Total Non-Current Assets	82.02M	33.28M	33.4M	33.16M	33.08M	32.94M	32.84M	33.26M
Total Liabilities	8.49M	8.61M	7.51M	6.84M	4.73M	5.65M	6M	128.98M
Total Current Liabilities	6.28M	6.48M	5.48M	4.9M	2.9M	3.9M	4.25M	6.03M
Total Non-Current Liabilities	2.21M	2.14M	2.04M	1.94M	1.84M	1.75M	1.75M	122.96M
Common Equity	14k	14k	14k	23k	24k	24k	25k	39k
Retained Earnings	-144.48M	-202.87M	-213.64M	-223.22M	-233.57M	-243.19M	-253.49M	-387.94M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	29.76M	20.89M	17.03M	10.93M	197.19M	170.55M	92.79M	89.07M
Total Current Assets	29.54M	19M	14.28M	9.97M	115.63M	88.35M	59.52M	56.13M
Cash and Equivalents	23.22M	17.23M	12.97M	8.79M	114.2M	84.83M	56.41M	4.61M
Total Non-Current Assets	26.86M	19.45M	14.49M	9.47M	190.6M	164M	84.18M	83.42M
Total Liabilities	2.9M	1.44M	2.53M	1.47M	6.59M	6.55M	8.61M	5.65M
Total Current Liabilities	2.82M	1.44M	2.53M	1.32M	2.48M	4.4M	6.48M	3.9M
Total Non-Current Liabilities	84k	0	0	144k	4.11M	2.15M	2.14M	1.75M
Total Equity	26.86M	19.45M	14.49M	9.47M	190.6M	164M	84.18M	83.42M
Common Equity	23k	7k	9k	13k	15k	14k	14k	24k
Retained Earnings	-169.4M	-27.51M	-41.57M	-57.58M	-80.39M	-114.9M	-202.87M	-243.19M